New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 8, 2013
09:11 EDTAXL, ATVI, WCRX, RVBD, WAG, AOL, LNKD, SKUL, NUAN, RSH, MCD, CXW, CSTR, ONCYOn The Fly: Pre-market Movers
UP AFTER EARNINGS/GUIDANCE: LinkedIn (LNKD), up 11.8%... Activision Blizzard(ATVI), up 8.6%... AOL (AOL), up 6.3%... American Axle (AXL), up 1.3%... ALSO HIGHER: RadioShack (RSH), up 6.8% after appointing former Walgreen (WAG) executive Joseph Magnacca as CEO... Oncolytics Biotech (ONCY), up 34.5% after announcing Phase 2 clinical trial data... DOWN AFTER EARNINGS/GUIDANCE: Nuance (NUAN), down 16.8%... Riverbed (RVBD), down 13.2%... Coinstar (CSTR), down 8.8%... Skullcandy (SKUL), down 8.3%... Warner Chilcott (WCRX), down 4.8%... ALSO LOWER: Corrections Corp. (CXW), down 3.3% after authorizing REIT conversion, declaring $650M-$700M special dividend... McDonald's (MCD), down 0.4% after reporting January global SSS down 1.9%.
News For LNKD;ATVI;MCD;AOL;AXL;RSH;WAG;ONCY;NUAN;RVBD;CSTR;SKUL;WCRX;CXW From The Last 14 Days
Check below for free stories on LNKD;ATVI;MCD;AOL;AXL;RSH;WAG;ONCY;NUAN;RVBD;CSTR;SKUL;WCRX;CXW the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
April 15, 2014
11:41 EDTRSHElectronics retailers sink after hhgregg lowers outlook
Subscribe for More Information
09:00 EDTRVBDElliott reaffirms $21 bid for Riverbed
Subscribe for More Information
08:12 EDTAXLBofA/Merrill to hold a summit
Subscribe for More Information
08:01 EDTAOLAOL launches premium video experience
AOL.com is launching a new premium video experience today. The experience will be programmed dynamically based on the insights around the AOL.com audience’s daily video viewing habits. This new experience on AOL.com expands on the success of the AOL On Network.
April 14, 2014
10:02 EDTLNKDOn The Fly: Analyst Initiation Summary
Subscribe for More Information
08:42 EDTLNKDLinkedIn initiated with an Overweight at Atlantic Equities
Atlantic Equities believes the recent pullback in shares of LinkedIn has created an attractive entry point. The firm started shares with an Overweight rating and $240 price target.
06:49 EDTONCYOncolytics Biotech reports evaluation of clinical study with REOLYSIN
Oncolytics Biotech announced that Dr. Adel Jebar of the Leeds Institute of Cancer and Pathology, University of Leeds, presented a poster at the 8th Annual International Conference on Oncolytic Virus Therapeutics held in Oxford, UK. Researchers examined REOLYSIN in panels of both normal and malignant liver cells and administered either REOLYSIN or saline to SCID mice with HCV-positive HCC xenografts. The aims of the study were to assess interferon secretion in normal and malignant liver cells in response to reovirus infection; the effects of reovirus infection in normal and malignant liver cells on HBV and HCV proteins; and the anti-viral and anti-cancer effects of reovirus in vivo. Based on these results, the investigators are evaluating the conduct of a translation clinical study.
06:47 EDTONCYOncolytics Biotech collaborators present preclinical research on liver cancer
Oncolytics Biotech announced that Dr. Adel Jebar of the Leeds Institute of Cancer and Pathology, University of Leeds, presented a poster at the 8th Annual International Conference on Oncolytic Virus Therapeutics held in Oxford, UK. Researchers examined Reolysin in panels of both normal and malignant liver cells and administered either Reolysin or saline to SCID mice with HCV-positive HCC xenografts. The aims of the study were to assess interferon secretion in normal and malignant liver cells in response to reovirus infection; the effects of reovirus infection in normal and malignant liver cells on HBV and HCV proteins; and the anti-viral and anti-cancer effects of reovirus in vivo. The study results showed that reovirus infection of primary human liver cells and HCC lines induced a robust type I interferon response; that reovirus-conditioned media from both primary human liver cells and JHH1 cells potently inhibits HCV and HBV in vitro with these effects abrogated by the blockade of the type I interferon receptor and soluble interferon beta; and that reovirus inhibits HCC xenograft growth and HCV replication in vivo. The researchers concluded that the results described a novel dual anti-viral and anti-cancer mechanism for reovirus in HBV/HCV-positive HCC and that reovirus treatment of patients with HBV/HCV positive HCC will likely lead to the suppression, rather than exacerbation, of the underlying oncogenic viral infection. Based on these results, the investigators are evaluating the conduct of a translation clinical study.
06:33 EDTONCYOncolytics Biotech collaborators present head, neck cancer biomarker poster
Subscribe for More Information
April 13, 2014
16:41 EDTWAGWalgreens investor group urges for re-domiciling tax base to Europe, FT says
Subscribe for More Information
April 11, 2014
12:42 EDTRVBDOn The Fly: Analyst Initiation Summary
ASML (ASML) initiated with a Cautious at ISI Group... Analog Devices (ADI) initiated with a Buy at ISI Group... Applied Materials (AMAT) initiated with a Strong Buy at ISI Group... Aruba Networks (ARUN) initiated with a Buy at SunTrust... Broadcom (BRCM) initiated with a Neutral at ISI Group... CSX (CSX) initiated with an Outperform at Macquarie... Cisco (CSCO) initiated with a Buy at SunTrust... F5 Networks (FFIV) initiated with a Neutral at SunTrust... Genesee & Wyoming (GWR) initiated with a Neutral at Macquarie... Intel (INTC) initiated with a Neutral at ISI Group... Juniper (JNPR) initiated with a Buy at SunTrust... KLA-Tencor (KLAC) initiated with a Neutral at ISI Group... Lam Research (LRCX) initiated with a Strong Buy at ISI Group... Linear Technology (LLTC) initiated with a Cautious at ISI Group... Maxim Integrated (MXIM) initiated with a Neutral at ISI Group... Micron (MU) initiated with a Strong Buy at ISI Group... NVIDIA (NVDA) initiated with a Neutral at ISI Group... NXP Semiconductors (NXPI) initiated with a Strong Buy at ISI Group... Qualcomm (QCOM) initiated with a Strong Buy at ISI Group... Riverbed (RVBD) initiated with a Neutral at SunTrust... SanDisk (SNDK) initiated with a Neutral at ISI Group... Teradyne (TER) initiated with a Buy at ISI Group... Texas Instruments (TXN) initiated with a Neutral at ISI Group... Trulia (TRLA) initiated with a Neutral at Susquehanna... Union Pacific (UNP) initiated with a Neutral at Macquarie... Zillow (Z) initiated with a Positive at Susquehanna... Flamel Technologies (FLML) initiated with a Buy at Roth Capital... Parker Drilling (PKD) initiated with an Accumulate at Tudor Pickering.
09:08 EDTWAGWalgreens has a conference call hosted by JPMorgan
JPMorgan Analyst Gill will host a conference call with CEO Greg Wasson on April 17 at 2 pm.
08:00 EDTLNKDLinkedIn remains a favorite large cap name at Piper Jaffray
Piper Jaffray says LinkedIn remains one of its favorite long-term large cap names. The firm believes investors are overlooking two new opportunities for the company: the addition of Sales Solutions and the Ad API. Piper reiterates an Overweight rating on LinkedIn with a $270 price target.
07:59 EDTATVIActivision Blizzard could be pressured by lock-up expiration, says Argus
Subscribe for More Information
06:47 EDTLNKDSamsung ups S5 incentives to fend off rivals, Bloomberg says
Subscribe for More Information
06:08 EDTRVBDRiverbed initiated with a Neutral at SunTrust
Subscribe for More Information
April 10, 2014
11:28 EDTWAGWalgreens management to meet with BB&T
Subscribe for More Information
11:23 EDTWAGRite Aid hits 52-week high after results, sales view top estimates
Shares of retail drugstore Rite Aid (RAD) are rallying after the company's fourth quarter results and fiscal 2015 revenue outlook topped analysts' consensus estimates. WHAT'S NEW: This morning, Rite Aid reported fourth quarter adjusted earnings per share of 10c and revenue of $6.6B, compared to expectations of 4c and $6.54B, respectively. Q4 same store sales increased 2.1%. Rite Aid forecast FY15 EPS of 31c-42c, compared to the consensus of 35c. FY15 revenue was seen at $26B-$26.5B, ahead of the consensus $25.75B. FY15 same-store sales are expected by the company to be up 2.5%-4.5%. WHAT'S NOTABLE: Rite Aid also announced it has acquired RediClinic, which currently operates 30 clinics in the greater Houston, Austin and San Antonio areas. Rite Aid CEO John Standley said, “Our recent acquisitions of Health Dialog and RediClinic, our expanded partnership with McKesson and our continued commitment to investing in our store base have positioned us to transition our strategy from turnaround to growth as we more aggressively pursue opportunities to become a growing retail healthcare company.” PRICE ACTION: In late morning trading, Rite Aid rose 71c, or about 11%, to $7.11 on more than twice its average daily trading volume. Earlier in the session, the stock hit a fresh 52-week high of $7.39. Including today's advance, the stock is up approximately 300% over the past twelve months. OTHERS TO WATCH: Other retail drugstore operators include Walgreen Company (WAG) and CVS Caremark (CVS).
10:44 EDTLNKDStocks with call strike movement; FSLR LNKD
Subscribe for More Information
09:06 EDTCXWCCA announces David Garfinkle to succeed Todd Mullenger as CFO
CCA announced that David Garfinkle, who currently serves as the company's vice president of finance and controller, has been selected by the board to succeed Todd Mullenger as the company's CFO effective May 1. Mullenger has decided to step down as CFO, but will remain with the company for a two-year period to assist in the transition and to assist in various projects.
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use